Our previous studies (12, 24) have shown that among patients with MPN patients with myelofibrosis display a significantly reduced T-cell response to ARG1- and PD-L1-derived peptide epitopes as compared to patients with ET (12, 36). This evidence concerns the gene ARG1 and myeloproliferative disorder.